The Nephroprotective Properties of Recombinant Human Erythropoietin in Kidney Transplantation: Experimental Facts and Clinical Proofs

Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients

(2012) Z. Aydin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury

(2012) Paola Cassis et al.   KIDNEY INTERNATIONAL

Delayed Graft Function in the Kidney Transplant

(2011) A. Siedlecki et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Erythropoietin, erythropoiesis and beyond

(2011) S. Chateauvieux et al.   BIOCHEMICAL PHARMACOLOGY

Erythropoietin enhances immunostimulatory properties of immature dendritic cells

(2011) F. Rocchetta et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy

(2011) G. Choukroun et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

RGS4, a GTPase activator, improves renal function in ischemia–reperfusion injury

(2011) Andrew M. Siedlecki et al.   KIDNEY INTERNATIONAL

High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation

(2011) Carsten Hafer et al.   KIDNEY INTERNATIONAL

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo-PDGF Study

(2010) F. Martinez et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine

(2010) D. W. Hanto et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tumor Necrosis Factor α Primes Cerebral Endothelial Cells for Erythropoietin-Induced Angiogenesis

(2010) Lei Wang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)

(2010) Zoltán H. Endre et al.   KIDNEY INTERNATIONAL

The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease

(2010) Imari Mimura et al.   Nature Reviews Nephrology

Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres

(2010) Miklos Zsolt Molnar et al.   NEPHRON CLINICAL PRACTICE

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

(2010) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular Basis of Cardioprotection by Erythropoietin

(2010) D. Burger et al.   Current Molecular Pharmacology

Erythropoietin to Augment Myocardial Salvage Induced by Coronary Thrombolysis in Patients With ST Segment Elevation Acute Myocardial Infarction

(2009) Azan S. Binbrek et al.   AMERICAN JOURNAL OF CARDIOLOGY

Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients

(2009) Noritaka Kawada et al.   Clinical and Experimental Nephrology

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET

(2009) T. Philipp et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

(2009) Marc A. Pfeffer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation

(2009) Cyril Moers et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity

(2009) Nicolas Pallet et al.   PHARMACOLOGICAL RESEARCH

Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model

(2009) W. M. Bernhardt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Carbamylated Erythropoietin Improves Angiogenesis and Protects the Kidneys from Ischemia-Reperfusion Injury

(2008) Ryoichi Imamura et al.   CELL TRANSPLANTATION

Impact of Anemia after Renal Transplantation on Patient and Graft Survival and on Rate of Acute Rejection

(2008) D. Chhabra et al.   Clinical Journal of the American Society of Nephrology

Asialoerythropoietin Prevents Contrast-Induced Nephropathy

(2008) Y. Yokomaku et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

(2008) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway

(2008) William G. Kaelin et al.   MOLECULAR CELL

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

(2008) M. Brines et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Negative Impact of One-Year Anemia on Long-Term Patient and Graft Survival in Kidney Transplant Patients Receiving Calcineurin Inhibitors and Mycophenolate Mofetil

(2008) Nassim Kamar et al.   TRANSPLANTATION

Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: A matched control study

(2007) Alain Cariou et al.   RESUSCITATION